We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M Turnover 79.96%
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
Cap. Flow
-$37.3M
Cap. Flow %
-11.13%
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134
Avg Time Held Equity + Options
0.1 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.1 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.1 years

Top Buys

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$16M
2
STM icon
STMicroelectronics
STM
+$13.6M
3
APH icon
Amphenol
APH
+$10.9M
4
STX icon
Seagate
STX
+$7.07M
5
F icon
Ford
F
+$6.02M

Top Sells

Rank Stock Value
1
SNDK icon
Sandisk
SNDK
+$18.4M
2
LITE icon
Lumentum
LITE
+$14.5M
3
AXTI icon
AXT Inc
AXTI
+$13.3M
4
TSEM icon
Tower Semiconductor
TSEM
+$11.9M
5
MU icon
Micron Technology
MU
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 38.35%
2 Healthcare 29.66%
3 Financials 6.33%
4 Miscellaneous 6.14%
5 Consumer Discretionary 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
INTC icon
1
Intel
INTC
$498B
$24.2M 7.21%
173,113
-101,276
-37% -$10.2M
2025 Q1
5 quarters
HOOD icon
2
Robinhood
HOOD
$90.3B
$19.2M 5.72%
+191,095
New +$16M
2026 Q2
0 quarters
STM icon
3
STMicroelectronics
STM
$41.3B
$16.9M 5.04%
+225,636
New +$13.6M
2026 Q2
0 quarters
APH icon
4
Amphenol
APH
$199B
$13.3M 3.97%
+151,004
New +$10.9M
2026 Q2
0 quarters
STX icon
5
Seagate
STX
$152B
$8.94M 2.67%
+9,265
New +$7.07M
2026 Q2
0 quarters
UTHR icon
6
United Therapeutics
UTHR
$23.1B
$7.58M 2.26%
13,981
+7,079
+103% +$3.99M
2025 Q4
2 quarters
RVMD icon
7
Revolution Medicines
RVMD
$39.3B
$7.25M 2.16%
38,726
+12,683
+49% +$1.85M
2025 Q2
4 quarters
SNOW icon
8
Snowflake
SNOW
$110B
$7.07M 2.11%
+27,783
New +$5.11M
2026 Q2
0 quarters
F icon
9
Ford
F
$49.5B
$6.2M 1.85%
+445,837
New +$6.02M
2026 Q2
0 quarters
ABVX icon
10
Abivax
ABVX
$7.81B
$5.9M 1.76%
44,256
+21,418
+94% +$2.42M
2025 Q3
3 quarters
AMAT icon
11
Applied Materials
AMAT
$335B
$5.62M 1.68%
+7,780
New +$3.59M
2026 Q2
0 quarters
COGT icon
12
Cogent Biosciences
COGT
$5.21B
$5.35M 1.6%
138,272
+45,756
+49% +$1.6M
2024 Q4
6 quarters
KLAC icon
13
KLA
KLAC
$223B
$4.96M 1.48%
+16,442
New +$3.26M
2026 Q2
0 quarters
BMRN icon
14
BioMarin Pharmaceuticals
BMRN
$10.6B
$4.57M 1.36%
79,933
+42,461
+113% +$2.33M
2024 Q4
6 quarters
VKTX icon
15
Viking Therapeutics
VKTX
$3.24B
$4.4M 1.31%
112,736
-20,330
-15% -$657K
2025 Q1
5 quarters
CDNS icon
16
Cadence Design Systems
CDNS
$88.9B
$4.17M 1.24%
+11,111
New +$3.89M
2026 Q2
0 quarters
LRCX icon
17
Lam Research
LRCX
$343B
$3.82M 1.14%
+8,824
New +$2.68M
2026 Q2
0 quarters
SMTC icon
18
Semtech
SMTC
$13.4B
$3.54M 1.06%
21,849
-9,506
-30% -$1.24M
2026 Q1
1 quarter
HON icon
19
Honeywell
HON
$66.8B
$3.46M 1.03%
+15,450
New +$3.45M
2026 Q2
0 quarters
HONA
20
Honeywell Aerospace
HONA
$52.6B
$3.42M 1.02%
+15,450
New +$3.41M
2026 Q2
0 quarters
WDC icon
21
Western Digital
WDC
$131B
$3.1M 0.93%
+4,859
New +$2.36M
2026 Q2
0 quarters
SNDK icon
22
Sandisk
SNDK
$200B
$3.09M 0.92%
1,360
-12,920
-90% -$18.4M
2025 Q4
2 quarters
EWTX icon
23
Edgewise Therapeutics
EWTX
$4.13B
$2.82M 0.84%
69,441
+59,388
+591% +$2.05M
2025 Q4
2 quarters
LFUS icon
24
Littelfuse
LFUS
$9.8B
$2.7M 0.81%
+5,927
New +$2.57M
2026 Q2
0 quarters
GLW icon
25
Corning
GLW
$115B
$2.39M 0.71%
9,368
-49,720
-84% -$9.05M
2025 Q4
2 quarters

Similar funds

Persistent Asset Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.

  • Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
  • Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
  • Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
  • Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
  • Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
  • Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
  • Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.